Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2018 Filed May 16, 2018 22:01 UTC |
Anicetti Vincent RChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $16.75 | $0.00 |
DisclosureSEC source: 0000899243-18-013087 · doc4.xml · derivative · entry 2 Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-05-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from May 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 09, 2018 Filed May 11, 2018 16:07 UTC |
NUSSBAUM SAMUEL R MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0000899243-18-012528 · doc4.xml · derivative · entry 1 NUSSBAUM SAMUEL R MD · CIK 0001199310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-09 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 9, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:09 UTC |
Anicetti Vincent RChief, Quality & Compliance
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $9.80 | $0.00 |
DisclosureSEC source: 0000899243-18-006333 · doc4.xml · derivative · entry 2 Anicetti Vincent R · CIK 0001733375 · Chief, Quality & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-03-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 16:07 UTC |
Watler Peter K.Chief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002891 · doc4.xml · derivative · entry 2 Watler Peter K. · CIK 0001622139 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:05 UTC |
Wahlstrom MatsDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002881 · doc4.xml · derivative · entry 3 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002885 · doc4.xml · derivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:05 UTC |
Lanfear Dennis MDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002883 · doc4.xml · derivative · entry 4 Lanfear Dennis M · CIK 0001420822 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-02-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:07 UTC |
Szela Mary TDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002889 · doc4.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 16:07 UTC |
LAWLIS V BRYANDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002888 · doc4.xml · derivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 16:08 UTC |
HEALY JAMESDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002892 · doc4.xml · derivative · entry 3 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:06 UTC |
FINCK BARBARA KChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002886 · doc4.xml · derivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:07 UTC |
Troendle August J.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002890 · doc4.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:07 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002884 · doc4.xml · derivative · entry 1 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:05 UTC |
Richards ChristosDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002880 · doc4.xml · derivative · entry 2 Richards Christos · CIK 0001622055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 16:05 UTC |
Watler Peter K.Chief Technical Officer
|
GrantCommon Stock, $0.0001 par value | 5,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029151 · doc4.xml · nonDerivative · entry 1 Watler Peter K. · CIK 0001622139 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
GrantCommon Stock, $0.0001 par value | 6,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029149 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,958 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:05 UTC |
Lanfear Dennis MDirector · See Remarks
|
GrantCommon Stock, $0.0001 par value | 20,984 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029150 · doc4.xml · nonDerivative · entry 1 Lanfear Dennis M · CIK 0001420822 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,619 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:06 UTC |
FINCK BARBARA KChief Medical Officer
|
GrantCommon Stock, $0.0001 par value | 7,545 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029152 · doc4.xml · nonDerivative · entry 1 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,336 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:07 UTC |
Herman Alan C.Chief Scientific Officer
|
GrantCommon Stock, $0.0001 par value | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029155 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,460 Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 17,535 | $15.02 | $263,300.30 |
DisclosureSEC source: 0000899243-17-020046 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,651 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $15.00 to $15.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 16:05 UTC |
Watler Peter K.Chief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 67,000 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000899243-17-019842 · doc4.xml · derivative · entry 1 Watler Peter K. · CIK 0001622139 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2027-08-06 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 67,000 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000899243-17-019841 · doc4.xml · derivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2027-08-06 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 20:05 UTC |
Lanfear Dennis MDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000899243-17-019839 · doc4.xml · derivative · entry 4 Lanfear Dennis M · CIK 0001420822 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-08-06 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 67,000 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000899243-17-019840 · doc4.xml · derivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2027-08-06 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 600 | $15.00 | $9,000.00 |
DisclosureSEC source: 0000899243-17-018067 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,186 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 1,732 | $20.98 | $36,342.04 |
DisclosureSEC source: 0000899243-17-015285 · doc4.xml · nonDerivative · entry 2 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,786 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $20.90 to $21.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 9,601 | $20.20 | $193,949.80 |
DisclosureSEC source: 0000899243-17-015285 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,518 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $19.85 to $20.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:05 UTC |
Wahlstrom MatsDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013888 · doc4.xml · derivative · entry 5 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F5 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:06 UTC |
Szela Mary TDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013898 · doc4.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 16:06 UTC |
LAWLIS V BRYANDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013896 · doc4.xml · derivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 16:05 UTC |
HEALY JAMESDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013894 · doc4.xml · derivative · entry 3 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:07 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013900 · doc4.xml · derivative · entry 1 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:05 UTC |
Troendle August J.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013892 · doc4.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:05 UTC |
Richards ChristosDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $23.80 | $0.00 |
DisclosureSEC source: 0000899243-17-013889 · doc4.xml · derivative · entry 2 Richards Christos · CIK 0001622055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-05-17 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 09, 2017 Filed May 19, 2017 20:05 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 109,957 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-013888 · doc4.xml · nonDerivative · entry 4 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 219,914 F4 · kind: KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F3 · ownership.nature: The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| May 09, 2017 Filed May 19, 2017 20:05 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-013888 · doc4.xml · nonDerivative · entry 3 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 178,528 F4 · kind: KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F2 · ownership.nature: The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 11,333 | $20.00 | $226,626.00 |
DisclosureSEC source: 0000899243-17-011610 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,119 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $19.25 to $20.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:06 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 11,333 | $20.73 | $234,985.22 |
DisclosureSEC source: 0000899243-17-009488 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,452 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $20.45 to $21.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 11,333 | $24.19 | $274,171.34 |
DisclosureSEC source: 0000899243-17-006341 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,785 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $23.85 to $24.625, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 22, 2017 Filed May 19, 2017 20:05 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 109,957 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-013888 · doc4.xml · nonDerivative · entry 2 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 109,957 F1 · kind: KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F3 · ownership.nature: The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| February 22, 2017 Filed May 19, 2017 20:05 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-013888 · doc4.xml · nonDerivative · entry 1 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 378,528 F1 · kind: KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F2 · ownership.nature: The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:05 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 11,333 | $27.37 | $310,154.74 |
DisclosureSEC source: 0000899243-17-002713 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,118 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $26.95 to $27.95, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,900 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-17-002094 · doc4.xml · derivative · entry 3 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,481 Underlying: Common Stock · 3,900 shares Expires 2024-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
SaleCommon Stock, $0.0001 par value | 3,900 | $27.00 | $105,300.00 |
DisclosureSEC source: 0000899243-17-002094 · doc4.xml · nonDerivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,992 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 3,900 | $13.50 | $52,650.00 |
DisclosureSEC source: 0000899243-17-002094 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:07 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 683 | $28.60 | $19,536.33 |
DisclosureSEC source: 0000899243-17-000442 · doc4.xml · nonDerivative · entry 2 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,451 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $28.525 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:07 UTC |
Herman Alan C.Chief Scientific Officer
|
SaleCommon Stock, $0.0001 par value | 10,650 | $27.90 | $297,186.12 |
DisclosureSEC source: 0000899243-17-000442 · doc4.xml · nonDerivative · entry 1 Herman Alan C. · CIK 0001622080 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,134 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $27.50 to $28.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 667 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-16-036028 · doc4.xml · derivative · entry 5 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,381 Underlying: Common Stock · 667 shares Expires 2024-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 667 | $13.50 | $9,004.50 |
DisclosureSEC source: 0000899243-16-036028 · doc4.xml · nonDerivative · entry 3 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,900 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-16-036028 · doc4.xml · derivative · entry 4 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,048 Underlying: Common Stock · 3,900 shares Expires 2024-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.